The Independent Valuation is out.
You have to go to another site to download it. Starts with Share ends with scene.
It should be noted that this is a sum-of-parts valuation and not a valuation of the Company per se. A Company valuation would consider life to perpetuity, usuallyachieved through the inclusion of a terminal value, and additional expenses, such as continuing research and development to ensure sustainability, with the net effect that a Company valuation would be higher than presented here. Although such an analysis requires access to additional information concerning the Company and its prospects, a rough analysis suggests a valuation range from $410 million ($1.80 per share) to $515
million ($2.26 per share).
- Forums
- ASX - By Stock
- independent valuation
AAH
arana therapeutics limited
The Independent Valuation is out.You have to go to another site...
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
Currently unlisted public company.
The Watchlist
NUZ
NEURIZON THERAPEUTICS LIMITED
Dr Michael Thurn, CEO & MD
Dr Michael Thurn
CEO & MD
SPONSORED BY The Market Online